(19)
(11) EP 2 579 894 A1

(12)

(43) Date of publication:
17.04.2013 Bulletin 2013/16

(21) Application number: 11792989.3

(22) Date of filing: 07.06.2011
(51) International Patent Classification (IPC): 
A61K 39/395(2006.01)
(86) International application number:
PCT/US2011/039381
(87) International publication number:
WO 2011/156324 (15.12.2011 Gazette 2011/50)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME

(30) Priority: 10.06.2010 US 353323 P

(71) Applicant: Eli Lilly and Company
Indianapolis, IN 46285 (US)

(72) Inventors:
  • ALLAN, Barrett
    Indianapolis Indiana 46206-6288 (US)
  • BENSCHOP, Robert Jan
    Indianapolis, Indiana 46206-6288 (US)
  • CHAMBERS, Mark Geoffrey
    Indianapolis Indiana 46206-6288 (US)
  • DARLING, Ryan James
    Indianapolis Indiana 46206-6288 (US)

(74) Representative: O'Connor, David 
Eli Lilly and Company Limited Lilly Research Centre Erl Wood Manor Sunninghill Road
Windlesham, Surrey GU20 6PH
Windlesham, Surrey GU20 6PH (GB)

   


(54) CGRP ANTIBODIES